With the flow of millions of Syrian refugees, Turkish higher education is facing the challenge of including ever growing numbers of refugee students to its system and preparing the system and institutions to their access, participation and inclusion. Although Turkey has taken crucial steps to provide refugees with access to higher education by revising and improving its legal framework, enrollment rates –which is above the world average of %1- are still low and needs further improvement along with the need to focus on their participation both educational and employment level. There is an apparent need to understand the multifaceted, complex needs of refugee students, and to assure their integration into the system. HEIs’ recognition and understanding of the refugee students, researchers would not only contribute to their access and participation to academy, job market, eventual success and empowerment but would further increase the awareness regarding their value and diversity in the society. Therefore. with the aim of increasing effective cooperation with science and society and pairing science with social awareness and responsibility the project oversees the inclusion and participation of refugee students and researchers to HES in Turkey through the piloting of specifically tailored support mechanisms, general staff trainings, good practice and knowledge sharing with increased communication and cooperation.
Intimate partner violence (IPV) is a prevalent problem with comparably more adverse effects on women. Therefore, the current action will aim to prepare an implement an intervention against IPV with an emphasis on women victims. Proximal antecedents to violent episodes have been shown to be the most significant predictor of IPV occurrence. Therefore, three intervention manuals will be prepared for victims, perpetrators, and couples focusing on proximal antecedents to violent episodes (Objective 1). These manuals will be tailored to the differential needs of victims concerning the findings of the inquiry of victim typologies (Objective 2), perpetrators concerning the existing perpetrator typologies and couples. Findings related to objectives 1 and 2 will be theoretically reviewed for suitability to adolescence during the secondment. Implementation of the manual for victims will be held during the (re)integration (Objective 3). Implementations for perpetrators and couples will take place following the end of the action due to time constraints. Research experience of the researcher with IPV victims will be transferred to the host organisation in return for research and practice experience of the host organisation with perpetrators and couples. This two-way transfer will support the independent future career of the researcher. The outputs of the action will be communicated with society starting with the implementation of the intervention for women victims. The host organisation, the secondment, and the beneficiary have a longstanding history of inclination towards participatory research supporting the communicability of the action. This successful history of experience will support the security and the applicability of the action against potential risks of feasibility.
IgG4-autoimmune diseases (IgG4-AID) are rare but collectively correspond to a significant group of devastating diseases affecting many different organs, e.g. skin, brain, nerves and kidney in patients that often remain unresponsive to current treatments. IgG4-AID have commonalities indicating a shared underlying immunopathogenesis that make a joint approach to identify new therapeutic targets and test new treatment strategies feasible and necessary. We hypothesize that genetic risk factors and a dysregulated immune response may lead to an increased susceptibility to produce antibodies targeting self-proteins. These are of a special subclass called IgG4, which are usually harmless but can cause disease in these patients by interfering with normal functions in the body. We are the first consortium that aims to study IgG4-AID comparatively, including pathogenic IgG4, and the cells, molecules and mechanisms involved in IgG4 autoantibody production, using an explorative multi-omics approaches in combination with state-ofthe- art cell and molecular biology methodology. We will establish a new humanized mouse model of IgG4-AID for the development and testing of a novel immune-apheresis based therapy aimed as immediate relief therapy for all IgG4-AID patients. Our innovative training program combines university-based and multidisciplinary research-based training with state-of the art web-based training and in-person trainings by the academic and non-academic sector. We aim to foster a new generation of experts in IgG4-AID that are 1) are highly employable both in the academic and industry sectors and qualified for innovative multidisciplinary translational research with a focus on biomedical product development and 2) equipped with the skillsets for digitalization, awareness for gender equality and diversity and competent in sustainable research and innovation approaches to address current and future challenges, such as climate change, social inequalities and pandemics.